Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders (Q24657681)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q85544163)
(P304) 5663-71
(P407) (Q1860)
(P433) 12
(P478) 111
(P577) Sunday, June 15, 2008
(P921) (Q7141)
(Q181600)
(Q70071943)
(Q1898104)
(Q37187)
(P1433) (Q885070)
(P1476) "Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders" (language: en)
(P2093) Cynthia Serdikoff
Mahfuza Jan
Cezary R Swider
Candy Robinson
Shi Yang
Thelma Angeles
Stephen G Emerson
Martin Carroll
Bruce Ruggeri
Pawel Dobrzanski
(P2860) (Q27824808)
(Q27824793)
(Q28241887)
(Q28217482)
(Q28262734)
(Q28277030)
(Q29547900)
(Q29614280)
(Q29618851)
(Q29614337)
(Q29618853)
(Q29618610)
(Q34770384)
(Q33371084)
(Q35849674)
(Q40330808)
(Q34296252)
(Q34262444)
(Q34183674)
(Q34126053)
(Q43899710)
(Q52259217)
(Q44008600)
(Q53625976)
(Q44863927)
(Q44104227)
(Q44016726)
(Q43808488)
(Q43684737)
(Q71029660)
(Q83310312)
(Q57589520)
other details
description scientific article

External Links